Anoro® Ellipta® (umeclidinium/vilanterol) gains approval in Japan for the treatment of COPD
GlaxoSmithKline plc and Theravance, Inc. announced that the Japanese Ministry…
4 July 2014 | By GlaxoSmithKline
GlaxoSmithKline plc and Theravance, Inc. announced that the Japanese Ministry of Health, Labour and Welfare has approved Anoro® Ellipta® (umeclidinium/vilanterol) for the relief of various symptoms due to airway obstruction with chronic obstructive pulmonary diseases...